Copyright
©The Author(s) 2021.
World J Hepatol. Jan 27, 2021; 13(1): 66-79
Published online Jan 27, 2021. doi: 10.4254/wjh.v13.i1.66
Published online Jan 27, 2021. doi: 10.4254/wjh.v13.i1.66
Ref. | Patients | Treatment duration | Mean number of stents | Number of ERCPs | Success rate |
Costamagna et al[41], 2001 | 45 | 12.1 mo (range 2-24 mo) | 3.2 (range 1-6) | 4.1 (range 2-8) | 89% (40/45) |
Hsieh et at[23], 2012 | 41 | 5.3 (range 3.8-8.9) | 7.0 (range 4-10) | 4.0 (range 3.0-5.3) | 100% (41/41) |
Morelli et al[43], 2008 | 38 | 107 d (range 20-198 d) | 2.5 (range 1-6) | 3.4 (range 2-6) | 87% (33/38) |
Pasha et al[90], 2004 | 25 | 3.3 mo (range, 2.2-7 mo) | 2.0 (range 1-4) | 3.5 (range 1-9) | 88% (22 of 25) |
Tabibian et al[42], 2010 | 69 | 15 mo (range 12-60 mo) | 3.0 (range 2-7) | 2.5 (range 2-5) | 94% (65/69) |
- Citation: Boeva I, Karagyozov PI, Tishkov I. Post-liver transplant biliary complications: Current knowledge and therapeutic advances. World J Hepatol 2021; 13(1): 66-79
- URL: https://www.wjgnet.com/1948-5182/full/v13/i1/66.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i1.66